Jianmei Wei
Bristol-Myers Squibb
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Jianmei Wei.
Tetrahedron Letters | 1993
Shu-Hui Chen; Jianmei Wei; Vittorio Farina
2-Deoxy taxol 2 was prepared in nine steps from baccatin III; the key step of the synthesis is a Barton-type deoxygenation at C-2. The compound was found to possess much reduced antitumor activity with respect to taxol.
Tetrahedron | 1993
Shu-Hui Chen; Stella Huang; Jianmei Wei; Vittorio Farina
Abstract Several Lewis acids were shown to cleanly open the oxetane ring of taxol and baccatin derivatives. The reaction is shown to proceed via anchimeric assistance by the C-4 acetate group. Several minor products, including a novel derivative possessing a bridged C-ring, were also isolated. A mechanistic rationale is provided for all compounds formed. When taxol derivatives were treated with Lewis acids in methanol, ester cleavage reactions were observed. We provide conditions that are selective for C-10 acetate cleavage and for C-13 side-chain methanolysis.
Bioorganic & Medicinal Chemistry Letters | 1994
Shu-Hui Chen; Vittorio Farina; Jianmei Wei; Bryon Long; Craig R. Fairchild; Stephen W. Mamber; John F. Kadow; Dolatrai M. Vyas; Terrence W. Doyle
Abstract Red-Al was used to selectively remove the C 2 benzoate of 7,13-bisTES baccatin ( 8 ). Derivatization of the resulting C 2 hydroxy compound provided the corresponding p-nitrophenyl carbamate, the p-methoxy and p-nitrobenzoates, and cyclohexyl ester. Attachment of the taxol side chain to the above four analogs via lactam ( 15 ) followed by desilylation provided five analogs of taxol modified at the C 2 position, including a C 1,2 cyclic carbonate. These five analogs were less potent than taxol in a tubulin polymerization assay and a cytotoxicity assay against human colon cancer cell line.
Bioorganic & Medicinal Chemistry Letters | 1995
Shu-Hui Chen; Jianmei Wei; Byron H. Long; Craig A. Fairchild; Joan M. Carboni; Steven W. Mamber; William C. Rose; Kathy A. Johnston; Anna Maria Casazza; John F. Kadow; Vittorio Farina; Dolatrai M. Vyas; Terrence W. Doyle
Abstract A large number of C-4 paclitaxel analogs have been prepared in the course of our systematic C-4 modification. These include C-4 esters, carbonates, carbamates as well as a C-4 deacetyl derivative. All of these analogs were evaluated in a tubulin polymerization assay as well as in a cytotoxicity assay against a human colon cancer cell line. The potent analogs emerging from these in vitro assays were further evaluated in vivo. With the exception of paclitaxel side chain bearing C-4 carbamates and C-4 aromatic esters, most of the C-4 aliphatic esters and carbonates were found to possess comparable or superior activity to paclitaxel in vitro. Several C-4 aliphatic esters and carbonates also exhibited in vivo activities against i.p. implanted murine M-109 lung carcinoma.
Bioorganic & Medicinal Chemistry Letters | 1994
Shu-Hui Chen; Joydeep Kant; Stephen W. Mamber; Gregory P. Roth; Jianmei Wei; Daniel R. Marshall; Dolatrai M. Vyas; Vittorio Farina; Annamaria Casazza; Byron H. Long; William C. Rose; Kathy A. Johnston; Craig R. Fairchild
Abstract A series of taxol derivatives, modified at C-7, is described. This includes sulfonate, silylether, ester, carbonate, carbamate, fluoro, dehydro and deoxy derivatives. Biological evaluation shows that these modifications do not usually significantly compromise activity. However, none of the C-7 analogs prepared thus far have been shown to be better than taxol in both in vitro and in vivo assays.
Bioorganic & Medicinal Chemistry Letters | 2001
Milind Deshpande; Jianmei Wei; Guangxiang Luo; Christopher Cianci; Stephanie Danetz; A. Torri; Laurence Tiley; Mark Krystal; Kuo-Long Yu; Stella Huang; Qi Gao; Nicholas A. Meanwell
Structure-activity studies associated with the salicylic acid-derived inhibitor of influenza fusion, BMY-27709, were examined using a parallel synthesis approach. This SAR survey led to the discovery of potent influenza inhibitory activity in a series of aromatic amides and thioamides derived from 1,3,3-trimethyl-5-hydroxycyclohexylmethylamine. Select compounds were characterized as inhibitors of the H1 subtype of influenza A viruses that act by preventing the pH-induced fusion process, thereby blocking viral entry into host cells. In a plaque-reduction assay, the most potent inhibitors displayed EC(50) values of 0.02-0.14 microg/mL.
Bioorganic & Medicinal Chemistry Letters | 2000
Keith D. Combrink; H. Belgin Gulgeze; Kuo-Long Yu; Bradley C. Pearce; Ashok K. Trehan; Jianmei Wei; Milind Deshpande; Mark Krystal; Albert Torri; Guangxiang Luo; Christopher Cianci; Stephanie Danetz; Laurence Tiley; Nicholas A. Meanwell
Structural variation of the quinolizidine heterocycle of the influenza fusion inhibitor BMY-27709 was examined by several topological dissections in order to illuminate the critical features of the ring system. This exercise resulted in the identification of a series of synthetically more accessible decahydroquinolines that retained the structural elements of BMY-27709 important for antiviral activity. The 2-methyl-cis-decahydroquinoline 6f was the most potent influenza inhibitor identified that demonstrated an EC50 of 90 ng/mL in a plaque reduction assay.
Tetrahedron Letters | 1993
Shu-Hui Chen; Jianmei Wei; Dolatrai M. Vyas; Terrence W. Doyle; Vittorio Farina
Abstract 7,10-Dideoxy taxol 2 was prepared from baccatin III in 4 steps via the Barton deoxygenation reaction. Similarly, 7-epi-10-deoxy taxol 3 was prepared in one step from 7-epi taxol in high yield. The key reaction was the tributyllin hydride- mediated direct reduction of the C 10 acetate.
Journal of Organic Chemistry | 1993
Shu-Hui Chen; Stella Huang; Joydeep Kant; Craig R. Fairchild; Jianmei Wei; Vittorio Farina
Journal of Organic Chemistry | 1993
Shu-Hui Chen; Stella Huang; Jianmei Wei; Vittorio Farina